Episode 71: MAGE-A4/MAGE-A8-targeted TCR-based bispecific T cell engager in recurrent and/or refractory solid tumors: a phase 1 trial
Science TLDR · Raymond Ruff
June 1, 202622m 9s
Audio is streamed directly from the publisher (raymondruff.github.io) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.